1. Home
  2. CCS vs NUVB Comparison

CCS vs NUVB Comparison

Compare CCS & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

N/A

Current Price

$57.79

Market Cap

1.7B

ML Signal

N/A

NUVB

Nuvation Bio Inc.

N/A

Current Price

$4.32

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCS
NUVB
Founded
2000
2018
Country
United States
United States
Employees
N/A
291
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CCS
NUVB
Price
$57.79
$4.32
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$70.50
$11.38
AVG Volume (30 Days)
206.8K
4.6M
Earning Date
04-22-2026
03-02-2026
Dividend Yield
2.08%
N/A
EPS Growth
N/A
N/A
EPS
4.86
N/A
Revenue
$4,117,816,000.00
N/A
Revenue This Year
N/A
$182.76
Revenue Next Year
$10.84
$91.83
P/E Ratio
$11.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.42
$1.57
52 Week High
$76.00
$9.75

Technical Indicators

Market Signals
Indicator
CCS
NUVB
Relative Strength Index (RSI) 34.89 35.73
Support Level $56.72 $4.16
Resistance Level $66.17 $5.55
Average True Range (ATR) 1.77 0.22
MACD -0.26 0.01
Stochastic Oscillator 32.73 27.29

Price Performance

Historical Comparison
CCS
NUVB

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: